The MCID (minimal clinically important difference) module of OMERACT 5 developed a research agenda that led to the conclusion that a state of low disease activity for rheumatoid arthritis (RA) would need to be defined. To develop such a definition the various concepts and terminologies, the process for developing an operational definition, and the availability and design of longitudinal datasets for validation needed to be considered. This article describes the process of the MCID/Low Disease Activity State Workshop at OMERACT 6 to develop such a definition.
|Number of pages||2|
|Journal||Journal of Rheumatology|
|Publication status||Published - 1 May 2003|
- Disease activity
- Outcome assessment
- Rheumatoid arthritis